We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$9.6B
AUM Growth
+$506M
Cap. Flow
-$208M
Cap. Flow %
-2.17%
Top 10 Hldgs %
16.85%
Holding
2,391
New
63
Increased
104
Reduced
1,016
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 18.02%
2 Financials 14.83%
3 Healthcare 13.13%
4 Industrials 10.01%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPTN
2101
DELISTED
NEOPHOTONICS CORP
NPTN
$159K ﹤0.01%
18,073
VSEC icon
2102
VSE Corp
VSEC
$6.73B
$159K ﹤0.01%
4,190
ALNT icon
2103
Allient
ALNT
$1.94B
$159K ﹤0.01%
4,925
BWB icon
2104
Bridgewater Bancshares
BWB
$609M
$159K ﹤0.01%
11,530
CUE icon
2105
Cue Biopharma
CUE
$115M
$159K ﹤0.01%
+334
New +$105K
GME icon
2106
GameStop
GME
$8.31B
$159K ﹤0.01%
104,284
-64,604
-38% -$94.9K
SLP icon
2107
Simulations Plus
SLP
$371M
$158K ﹤0.01%
5,451
MCB icon
2108
Metropolitan Bank Holding Corp
MCB
$1.17B
$158K ﹤0.01%
3,277
RCUS icon
2109
Arcus Biosciences
RCUS
$3.69B
$158K ﹤0.01%
15,645
REAL icon
2110
The RealReal
REAL
$1.42B
$157K ﹤0.01%
8,320
-6,780
-45% -$130K
NKSH icon
2111
National Bankshares
NKSH
$267M
$157K ﹤0.01%
3,487
HRTG icon
2112
Heritage Insurance Holdings
HRTG
$966M
$156K ﹤0.01%
11,792
RUBY
2113
DELISTED
Rubius Therapeutics, Inc
RUBY
$156K ﹤0.01%
16,410
CRAI icon
2114
CRA International
CRAI
$1.04B
$156K ﹤0.01%
2,862
DX
2115
Dynex Capital
DX
$3.23B
$156K ﹤0.01%
9,188
-5,707
-38% -$92.2K
DNTH icon
2116
Dianthus Therapeutics
DNTH
$6.13B
$155K ﹤0.01%
641
FC icon
2117
Franklin Covey
FC
$232M
$155K ﹤0.01%
4,809
TBRG
2118
DELISTED
TruBridge
TBRG
$155K ﹤0.01%
5,856
SMMF
2119
DELISTED
Summit Financial Group, Inc.
SMMF
$155K ﹤0.01%
5,705
APYX icon
2120
Apyx Medical
APYX
$126M
$154K ﹤0.01%
18,201
GTT
2121
DELISTED
GTT Communications, Inc.
GTT
$154K ﹤0.01%
13,560
SHOE
2122
Shoe Station Group
SHOE
$417M
$153K ﹤0.01%
8,228
INO icon
2123
Inovio Pharmaceuticals
INO
$78.1M
$153K ﹤0.01%
+3,873
New +$117K
SAFE
2124
DELISTED
Safehold Inc.
SAFE
$153K ﹤0.01%
3,796
EXPR
2125
DELISTED
Express, Inc.
EXPR
$153K ﹤0.01%
+1,566
New +$123K

Similar funds

MetLife Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, MetLife Investment Management held 2,391 positions worth $9.6B, up 5.6% from $9.09B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

MetLife Investment Management's Q4 2019 filing shows 63 new, 104 increased, 1,016 reduced and 90 closed positions. Its largest new stake was ServiceNow: 250,510 shares worth $14.1M. The largest sale was Celgene Corp, an estimated $19.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2019 buy was ServiceNow: 250,510 shares worth $14.1M.
  • MetLife Investment Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $10.2M increase.
  • MetLife Investment Management's biggest Q4 2019 reduction was Apple, cutting an estimated $12M.
  • MetLife Investment Management fully exited Celgene Corp in Q4 2019, selling an estimated $19.2M.
  • MetLife Investment Management's ten largest holdings make up 17% of its $9.6B portfolio in Q4 2019.
  • MetLife Investment Management opened 63 new positions and closed 90 in Q4 2019.
  • MetLife Investment Management's portfolio value rose 5.6% quarter-over-quarter to $9.6B.

Based on MetLife Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.